XML 33 R52.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Combinations (Pro Forma Information) (Details) - NPS Pharma - USD ($)
$ / shares in Units, $ in Millions
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Pro Forma Information    
Revenues $ 3,075.9 $ 2,949.0
Net income from continuing operations $ 526.6 $ 565.7
Net income from continuing operations per share - basic $ 0.959 $ 0.966
Net income from continuing operations per share - diluted $ 0.954 $ 0.958
Pro Forma Data Adjustments    
An adjustment to increase amortization of intangible assets $ (21.1) $ (83.6)
Increase/(decrease) to net income to reflect acquisition related costs 107.2 (107.2)
Decrease to net income to reflect the additional interest expense   (11.1)
Increase/(decrease) to net income to reflect the fair value adjustment to acquisition date inventory. $ 9.2 $ (9.2)